DK0625048T4 - Syntese af human procollagener og collagener i rekombinant DNA-systemer - Google Patents

Syntese af human procollagener og collagener i rekombinant DNA-systemer

Info

Publication number
DK0625048T4
DK0625048T4 DK92924122T DK92924122T DK0625048T4 DK 0625048 T4 DK0625048 T4 DK 0625048T4 DK 92924122 T DK92924122 T DK 92924122T DK 92924122 T DK92924122 T DK 92924122T DK 0625048 T4 DK0625048 T4 DK 0625048T4
Authority
DK
Denmark
Prior art keywords
collagen
collagens
synthesis
recombinant dna
human
Prior art date
Application number
DK92924122T
Other languages
Danish (da)
English (en)
Other versions
DK0625048T3 (da
Inventor
Darwin J Prockop
Andrzej Fertala
Aleksander Sieron
Kari I Kivirikko
Amy Geddis
Taina A Pihlajaniemi
Leena Ala-Kokko
Original Assignee
Fibrogen Inc
Univ Jefferson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25121036&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0625048(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fibrogen Inc, Univ Jefferson filed Critical Fibrogen Inc
Application granted granted Critical
Publication of DK0625048T3 publication Critical patent/DK0625048T3/da
Publication of DK0625048T4 publication Critical patent/DK0625048T4/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
    • C12Y114/11—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors (1.14.11)
    • C12Y114/11002—Procollagen-proline dioxygenase (1.14.11.2), i.e. proline-hydroxylase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • General Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
DK92924122T 1991-10-23 1992-10-22 Syntese af human procollagener og collagener i rekombinant DNA-systemer DK0625048T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78089991A 1991-10-23 1991-10-23
PCT/US1992/009061 WO1993007889A1 (fr) 1991-10-23 1992-10-22 Synthese de procollagenes et de collagenes humains dans des systemes d'adn de recombinaison

Publications (2)

Publication Number Publication Date
DK0625048T3 DK0625048T3 (da) 2000-05-29
DK0625048T4 true DK0625048T4 (da) 2006-02-20

Family

ID=25121036

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92924122T DK0625048T4 (da) 1991-10-23 1992-10-22 Syntese af human procollagener og collagener i rekombinant DNA-systemer

Country Status (12)

Country Link
US (1) US5405757A (fr)
EP (2) EP0625048B2 (fr)
JP (2) JP3302017B2 (fr)
AT (1) ATE188253T1 (fr)
AU (2) AU680606B2 (fr)
CA (1) CA2121698C (fr)
DE (1) DE69230502T3 (fr)
DK (1) DK0625048T4 (fr)
ES (1) ES2143478T5 (fr)
GR (1) GR3033022T3 (fr)
HK (1) HK1010334A1 (fr)
WO (1) WO1993007889A1 (fr)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020142391A1 (en) * 1991-06-12 2002-10-03 Kivirikko Kari I. Synthesis of human procollagens and collagens in recombinant DNA systems
US5667839A (en) * 1993-01-28 1997-09-16 Collagen Corporation Human recombinant collagen in the milk of transgenic animals
US6653450B1 (en) * 1993-01-28 2003-11-25 Cohesion Technologies, Inc. Mutated recombinant collagens
CA2152595A1 (fr) * 1993-10-25 1995-05-04 Shinji Kobayashi Chondrocalcine humaine purifiee, procede de production et utilisation de ce produit
EP0759932A4 (fr) * 1994-05-11 1997-11-19 Organo Genesis Inc Collagene obtenu a partir de cultures cellulaires
US6713662B1 (en) * 1994-07-27 2004-03-30 Pharming Intellectual Property B.V. Production of collagen in the milk of transgenic mammals
WO1997006242A1 (fr) * 1995-08-08 1997-02-20 Thomas Jefferson University Proteinase c de recombinaison et processus, procedes et utilisations
US6171827B1 (en) 1995-08-31 2001-01-09 The Victoria University Of Manchester Procollagens
WO1997014431A1 (fr) * 1995-10-20 1997-04-24 Collagen Corporation Production de procollagene recombinant dans la levure
US5773248A (en) * 1995-11-13 1998-06-30 Uab Research Foundation Nucleic acid encoding a human α3(IX) collagen protein and method of producing the protein recombinantly
JP2001510981A (ja) * 1995-11-13 2001-08-07 フィブロゲン，インコーポレーッテッド Ｉｘ型コラーゲンおよびキメラ
WO1997038710A1 (fr) * 1996-04-12 1997-10-23 Fibrogen, Inc. Synthese de procollagenes et de collagenes humains dans des systemes d'adn de recombinaison
US5856308A (en) * 1996-09-27 1999-01-05 Haemacure Corporation Artificial collagen
WO1998018918A1 (fr) * 1996-10-29 1998-05-07 Commonwealth Scientific And Industrial Research Organisation Expression stable de proteines a helice triple
AU780813B2 (en) * 1996-10-29 2005-04-21 Commonwealth Scientific And Industrial Research Organisation Stable expression of triple helical proteins
AUPO331096A0 (en) * 1996-10-29 1996-11-21 Commonwealth Scientific And Industrial Research Organisation Collagen products
FR2757874B1 (fr) * 1996-12-17 2003-04-25 Biocem Collagenes recombinants et proteines derivees produits par les plantes, leurs procedes d'obtention et leurs utilisations
GB9704305D0 (en) * 1997-03-01 1997-04-23 Univ Manchester Procollagen assembly
NL1007908C2 (nl) * 1997-12-24 1999-06-25 Fuji Photo Film Bv Zilverhalide-emulsies met recombinant collageen die geschikt zijn voor fotografische toediening alsmede de bereiding daarvan.
US6150081A (en) 1997-12-24 2000-11-21 Fuji Photo Film B.V. Silver halide emulsions with recombinant collagen suitable for photographic application and also the preparation thereof
DE19812713A1 (de) * 1998-03-24 1999-09-30 Merck Patent Gmbh Verfahren zur Herstellung von mineralisierten Kollagenfibrillen und deren Verwendung als Knochenersatzwerkstoff
JP2000125872A (ja) * 1998-09-07 2000-05-09 Terumo Corp 三量体キメラタンパク質およびキメラタンパク質を含有するコラーゲンマトリックス
EP1232181B1 (fr) * 1999-11-12 2013-03-27 Fibrogen, Inc. Gelatines de recombinaison
CA2399371A1 (fr) * 1999-11-12 2001-05-17 Fibrogen, Inc. Collagenes et gelatines animaux
EP1504033A2 (fr) 2002-05-03 2005-02-09 Millenium Biologix Inc. Peptides stimulant un tissu conjonctif
AU2003270593A1 (en) 2002-09-13 2004-04-30 Ocular Sciences, Inc. Devices and methods for improving vision
GB0309064D0 (en) 2003-04-22 2003-05-28 Univ Manchester Modified peptides and their uses
ES2387467T3 (es) * 2005-03-31 2012-09-24 Fuso Pharmaceutical Industries, Ltd. Procedimientos de producción de proteínas que tienen estructura helicoidal triple
AU2012200573B2 (en) * 2005-03-31 2013-11-07 Fuso Pharmaceutical Industries, Ltd. "Process for production of protein having triple-helical structure"
WO2007041627A1 (fr) 2005-10-03 2007-04-12 Pinsky Mark A Préparations et méthodes pour soin de la peau amélioré
US20080081353A1 (en) * 2006-09-29 2008-04-03 Universite Laval Production of recombinant human collagen
CA2706553A1 (fr) * 2007-12-26 2009-07-09 Mark A. Pinsky Formulations a base de collagene destinees a un soin cutane ameliore
CN102325882A (zh) 2008-12-22 2012-01-18 国立大学法人北海道大学 具有三螺旋结构的蛋白质物质及其制造方法
WO2012149136A1 (fr) 2011-04-26 2012-11-01 The Board Of Trustees Of The Leland Stanford Junior University Production et administration d'un collagène stable
TW201408695A (zh) * 2012-08-30 2014-03-01 Body Organ Biomedical Corp 重組載體及應用其而產生之轉基因魚卵與生物材料
FR3033697B1 (fr) * 2015-03-17 2020-03-27 Universite Pierre Et Marie Curie (Paris 6) Suspensions de collagene injectables, leur procede de preparation et leurs utilisations, notamment pour la formation de matrices denses de collagene
SG11202112632UA (en) * 2019-05-14 2021-12-30 Provenance Bio Llc Expression of modified proteins in a peroxisome
KR102135976B1 (ko) * 2019-10-24 2020-07-20 주식회사 에이바이오테크 콜라겐 합성 촉진 활성을 갖는 펩타이드 및 이를 이용한 방법
DE102021202830A1 (de) 2021-03-23 2022-09-29 Gelita Ag Rekombinantes Typ II-Kollagen zur therapeutischen Verwendung
WO2023194333A1 (fr) 2022-04-04 2023-10-12 Swiftpharma Bv Protéines de collagène recombinantes renforcées par de la soie d'araignée produites dans des plantes et leur utilisation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4376110A (en) * 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4645748A (en) * 1985-02-01 1987-02-24 Charles Hurwitz Protein which is characteristic of rheumatoid arthritis
US4840793A (en) * 1987-06-11 1989-06-20 Dana-Farber Cancer Institute Method of reducing tissue damage at an inflammatory site using a monoclonal antibody
US5147638A (en) * 1988-12-30 1992-09-15 Oklahoma Medical Research Foundation Inhibition of tumor growth by blockade of the protein C system
US5045449A (en) * 1989-06-14 1991-09-03 Thomas Jefferson University Methods of detecting a genetic predisposition for vascular aneurysms
US5136021A (en) * 1990-02-27 1992-08-04 Health Research, Inc. TNF-inhibitory protein and a method of production

Also Published As

Publication number Publication date
JP2002255999A (ja) 2002-09-11
ES2143478T3 (es) 2000-05-16
HK1010334A1 (en) 1999-06-17
EP0625048B2 (fr) 2005-10-26
DE69230502T2 (de) 2000-08-10
DK0625048T3 (da) 2000-05-29
WO1993007889A1 (fr) 1993-04-29
AU680606B2 (en) 1997-08-07
EP0962529A1 (fr) 1999-12-08
DE69230502T3 (de) 2006-05-24
ES2143478T5 (es) 2006-05-16
JPH07501939A (ja) 1995-03-02
GR3033022T3 (en) 2000-08-31
EP0625048A4 (fr) 1995-04-05
US5405757A (en) 1995-04-11
EP0625048A1 (fr) 1994-11-23
ATE188253T1 (de) 2000-01-15
CA2121698A1 (fr) 1993-04-29
AU4441497A (en) 1998-02-12
JP3302017B2 (ja) 2002-07-15
DE69230502D1 (de) 2000-02-03
EP0625048B1 (fr) 1999-12-29
CA2121698C (fr) 2010-05-18
AU3055592A (en) 1993-05-21

Similar Documents

Publication Publication Date Title
DK0625048T4 (da) Syntese af human procollagener og collagener i rekombinant DNA-systemer
NO954525D0 (no) BMP-10 sammensetninger
ATE175441T1 (de) Bmp-9 zusammensetzungen
ES2115662T3 (es) Modificacion genetica de celulas endoteliales.
ES2128330T3 (es) Material para la substitucion de huesos con factores de crecimiento de fibroblastos.
DE69528058D1 (de) Bmp-9 zusammensetzungen
DE69722681D1 (de) Verwendung von anti-mikrotubuli mitteln zur behandlung von entzündlichen darmerkrankungen
DK1584682T3 (da) Regulering af bcl-2 gene ekspression
ATE373672T1 (de) Synthese von methoxynukleoside und enzymatische nukleisäure moleküle
DE69901524D1 (de) Kosmetische Zusammensetzung enthaltend ein anionisches Polymer und ein acrylisches Terpolymer und Verwendung dieser Zusammensetzung zur Behandlung von Keratinfasern
ATE256740T1 (de) Menschliches sdf-5 protein und diesbezügliche zusammensetzungen
DE69630955T2 (de) Immortalisierung bzw. desimmortalisierung von zellen
PT1690874E (pt) Bmp-12, bmp-13 e suas composições indutoras de tendões
DK1237549T3 (da) Lipoxin A4 og dets analoger til behandling af törre öjne
DE69626981D1 (de) N-(2-oxo-2,3,4,5-tetrahydro-1h-1,5-benzodiazepin-3-yl)-3-amide
DK1028744T3 (da) Neuronale anvendelser af BMP-11
ATE79031T1 (de) Verwendung von ketonderivaten zur behandlung von depressionen.
BR0014183A (pt) Composições farmaceuticas e metodos de uso de proteìna relacionada frizzled secretada
DE69328193D1 (de) Verwendung von prodelphidinen zur behandlung von arthrose
DE69013871D1 (de) 4-Benzyl-5-phenyl-2,4-dihydro-3H-1,2,4-triazol-3-one und ihre Verwendung als Antikonvulsiva.
ATE222901T1 (de) Carboxylsubstituierte chromanderivate zur verwendung als beta 3 adrenorezeptor-agonisten
DE69328060D1 (de) Angiotensin-II Typ-1 Rezeptor und dessen Herstellung
ATE123942T1 (de) 5-aryl-3h-1,2,4-triazol-3-one und ihre verwendung als antikonvulsiva.
DE69022776D1 (de) Verwendung von keramischen Materialen als Ersatzmaterialien für lebendes Gewebe.
ATE208218T1 (de) Membransystem zur gesteuerten geweberegeneration bei erkrankungen des zahnhalteapparates